Dr. Guy Aumais, MD
Claim this profileCIUSS-de-L'Est-de-l'île-de-Montréal-Hôpital
Studies Ulcerative Colitis
Studies Ulcer
4 reported clinical trials
2 drugs studied
Affiliated Hospitals
CIUSS-de-L'Est-de-l'île-de-Montréal-Hôpital
Hopital Maisonneuve-Rosemont D/b/a CIUSSS De L'Est-de-l'Île-de-Montréal
Clinical Trials Guy Aumais, MD is currently running
ABX464
for Ulcerative Colitis
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies [corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)] and/or advanced therapies [biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors].
Recruiting1 award Phase 36 criteria
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
More about Guy Aumais, MD
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Guy Aumais, MD has experience with
- Mirikizumab
- ABX464
Breakdown of trials Guy Aumais, MD has run
Ulcerative Colitis
Inflammatory Bowel Disease
Crohn's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Guy Aumais, MD specialize in?
Guy Aumais, MD focuses on Ulcerative Colitis and Ulcer. In particular, much of their work with Ulcerative Colitis has involved treating patients, or patients who are undergoing treatment.
Is Guy Aumais, MD currently recruiting for clinical trials?
Yes, Guy Aumais, MD is currently recruiting for 3 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Guy Aumais, MD has studied deeply?
Yes, Guy Aumais, MD has studied treatments such as Mirikizumab, ABX464.
What is the best way to schedule an appointment with Guy Aumais, MD?
Apply for one of the trials that Guy Aumais, MD is conducting.
What is the office address of Guy Aumais, MD?
The office of Guy Aumais, MD is located at: CIUSS-de-L'Est-de-l'île-de-Montréal-Hôpital, Montreal, Quebec H1T 2M4 Canada. This is the address for their practice at the CIUSS-de-L'Est-de-l'île-de-Montréal-Hôpital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.